Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell membrane and its associated surface macromolecules constitute the essential boundary between a microorganism and its environment (StatPearls, 2023). This structure is composed of a lipid bilayer interspersed with proteins and specialized molecules like lipopolysaccharides (LPS) in Gram-negative bacteria or ergosterol in fungi (PubMed, 2021). Its primary biological functions include maintaining cellular homeostasis, regulating the transport of ions and nutrients, and providing a scaffold for energy-generating processes like the electron transport chain (NIH, 2022). In the context of infectious diseases, these components are vital for pathogen survival and virulence, making them effective targets for various antimicrobial agents. Drugs such as polymyxins and daptomycin exert their effects by binding to specific membrane components, leading to physical disruption, pore formation, and lethal depolarization of the cell (Journal of Antimicrobial Chemotherapy, 2020). Antifungal agents like amphotericin B specifically target ergosterol, creating channels that cause the leakage of intracellular contents (StatPearls, 2023). While highly effective, targeting these structures can sometimes lead to toxicity in humans if the drug lacks sufficient selectivity between microbial and host membranes. Overall, this target complex remains a cornerstone of treatment for multi-drug resistant infections.
Drugs targeting this complex typically act by binding to specific lipids or lipopeptides (e.g., LPS or ergosterol), leading to physical membrane disruption, the formation of transmembrane pores, rapid depolarization, and the leakage of essential intracellular ions like potassium (StatPearls, 2023; PubMed, 2022).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and associated surface macromolecules.